BIT
TBRA

BlackRock Institutional Trust’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlackRock Institutional Trust’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-108,719
Closed -$4.32M – 3956
2016
Q3 		$4.32M Buy
108,719
+32,318
+42% +$361K ﹤0.01% 2752
2016
Q2 		$960K Buy
76,401
+36,817
+93% +$343K ﹤0.01% 3317
2016
Q1 		$324K Sell
39,584
-948
-2% -$7.15K ﹤0.01% 3541
2015
Q4 		$407K Buy
40,532
+555
+1% +$5.76K ﹤0.01% 3543
2015
Q3 		$386K Buy
39,977
+26,250
+191% +$368K ﹤0.01% 3546
2015
Q2 		$237K Buy
13,727
+76
+0.6% +$1.11K ﹤0.01% 3609
2015
Q1 		$150K Sell
13,651
-23
-0.2% -$247 ﹤0.01% 3667
2014
Q4 		$112K Sell
13,674
-216
-2% -$1.86K ﹤0.01% 3703
2014
Q3 		$141K Sell
13,890
-12,660
-48% -$250K ﹤0.01% 3648
2014
Q2 		$1.62M Buy
26,550
+26,355
+13,515% +$1.6M ﹤0.01% 3278
2014
Q1 		$22K Buy
+195
New +$13.7K ﹤0.01% 3873

BlackRock Institutional Trust's TBRA Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 108,719 shares — an estimated $4.32M sold.

BlackRock Institutional Trust first reported a position in TBRA in Q1 2014 and held it in 11 quarters. The position peaked at $4.32M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 108,719 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $4.32M.
  • BlackRock Institutional Trust first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 11 quarters.
  • BlackRock Institutional Trust's Tobira Therapeutics, Inc. Common Stock position peaked at $4.32M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.